Search
01/05/2022
Increase of Circulating Monocyte-Platelet Conjugates in Rheumatoid Arthritis Responders to IL-6 Blockage
Mariscal, A, Zamora, C, Diaz-Torne, C, Ortiz, MA, de Agustin, JJ, Reina, D, Estrada, P, Moya, P, Corominas, H, Vidal, S. Increase of Circulating Monocyte-Platelet Conjugates in Rheumatoid Arthritis Responders to IL-6 Blockage. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(10)DOI:10.3390/ijms23105748. PMID:35628558. IF:5.600(Q1/3D).
25/03/2022
Prevalence and Risk for Bundle Branch Block, Atrioventricular Block and Pacemaker Implantation in Spondyloarthritis. A Systematic Review of the Literature
Park, HS, Laiz, A, del Campo, PD, Martinez, MAM, Guerra-Rodriguez, M, Alonso-Martin, C, Sanchez-Vega, J, Corominas, H. Prevalence and Risk for Bundle Branch Block, Atrioventricular Block and Pacemaker Implantation in Spondyloarthritis. A Systematic Review of the Literature. Frontiers in Medicine. 2022; 9DOI:10.3389/fmed.2022.851483. PMID:35402464. IF:3.900(Q2/4D).
16/02/2022
Effect of statin therapy on SARS-CoV-2 infection-related mortality in hospitalized patients
Masana, L, Correig, E, Rodriguez-Borjabad, C, Anoro, E, Arroyo, JA, Jerico, C, Pedragosa, A, la Miret, M, Naf, S, Pardo, A, Perea, V, Perez-Bernalte, R, Plana, N, Ramirez-Montesinos, R, Royuela, M, Soler, C, Urquizu-Padilla, M, Zamora, A, Pedro-Botet, J. Effect of statin therapy on SARS-CoV-2 infection-related mortality in hospitalized patients. European Heart Journal-Cardiovascular Pharmacotherapy. 2022; 8(2)DOI:10.1093/ehjcvp/pvaa128. PMID:33135047. IF:7.100(Q1/1D).
01/01/2022
Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis
Tornero-Molina, J, Alperi-Lopez, M, Castellvi, I, de Agustin-de Oro, JJ, Escudero, A, Garcia-Vicuna, R, Gonzalez-Gay, MA, Hidalgo, C, Rubio, E, Sanmarti, R, Casamira, N, Calvo-Alen, J. Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis. Reumatologia Clinica. 2022; 18(1)DOI:10.1016/j.reuma.2020.08.003. PMID:35090610. IF:(Q/D).
01/01/2024
Altered CD39 and CD73 Expression in Rheumatoid Arthritis: Implications for Disease Activity and Treatment Response
Ortiz, MA, Diaz-Torne, C, De Agustin, JJ, Estrada, P, Reina, D, Hernandez, MV, Sang, HY, Zamora, C, Canto, E, Corominas, H, Vidal, S. Altered CD39 and CD73 Expression in Rheumatoid Arthritis: Implications for Disease Activity and Treatment Response. Biomolecules. 2024; 14(1)DOI:10.3390/biom14010001. PMID:38275742. IF:4.800(Q1/3D).
01/01/2024
Initial Treatment with Biological Therapy in Rheumatoid Arthritis
Molina, JT, Hernández-Cruz, B, Corominas, H. Initial Treatment with Biological Therapy in Rheumatoid Arthritis. Journal of Clinical Medicine. 2024; 13(1)DOI:10.3390/jcm13010048. PMID:38202055. IF:2.900(Q1/2D).